667 related articles for article (PubMed ID: 18186465)
21. Insertion of externally administered amyloid beta peptide 25-35 and perturbation of lipid bilayers.
Dante S; Hauss T; Dencher NA
Biochemistry; 2003 Nov; 42(46):13667-72. PubMed ID: 14622013
[TBL] [Abstract][Full Text] [Related]
22. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
Takahashi T; Mihara H
Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
[TBL] [Abstract][Full Text] [Related]
23. Abeta42-peptide assembly on lipid bilayers.
Yip CM; Darabie AA; McLaurin J
J Mol Biol; 2002 Apr; 318(1):97-107. PubMed ID: 12054771
[TBL] [Abstract][Full Text] [Related]
24. Review: modulating factors in amyloid-beta fibril formation.
McLaurin J; Yang D; Yip CM; Fraser PE
J Struct Biol; 2000 Jun; 130(2-3):259-70. PubMed ID: 10940230
[TBL] [Abstract][Full Text] [Related]
25. A Langmuir monolayer study of the interaction of E1(145-162) hepatitis G virus peptide with phospholipid membranes.
Sánchez-Martín MJ; Haro I; Alsina MA; Busquets MA; Pujol M
J Phys Chem B; 2010 Jan; 114(1):448-56. PubMed ID: 20000622
[TBL] [Abstract][Full Text] [Related]
26. Perturbation of membranes by the amyloid beta-peptide--a molecular dynamics study.
Lemkul JA; Bevan DR
FEBS J; 2009 Jun; 276(11):3060-75. PubMed ID: 19490108
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanisms initiating amyloid beta-fibril formation in Alzheimer's disease.
Kirkitadze MD; Kowalska A
Acta Biochim Pol; 2005; 52(2):417-23. PubMed ID: 15933761
[TBL] [Abstract][Full Text] [Related]
28. Dynamic fluorescence imaging analysis to investigate the cholesterol recruitment in lipid monolayer during the interaction between beta-amyloid (1-40) and lipid monolayers.
Lin MS; Chen XB; Wang SS; Chang Y; Chen WY
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):59-66. PubMed ID: 19619991
[TBL] [Abstract][Full Text] [Related]
29. Surface chemistry of Alzheimer's disease: a Langmuir monolayer approach.
Thakur G; Micic M; Leblanc RM
Colloids Surf B Biointerfaces; 2009 Dec; 74(2):436-56. PubMed ID: 19726167
[TBL] [Abstract][Full Text] [Related]
30. Influence of fluorinated and hydrogenated nanoparticles on the structure and fibrillogenesis of amyloid beta-peptide.
Rocha S; Thünemann AF; Pereira Mdo C; Coelho M; Möhwald H; Brezesinski G
Biophys Chem; 2008 Sep; 137(1):35-42. PubMed ID: 18625543
[TBL] [Abstract][Full Text] [Related]
31. Cross-strand pairing and amyloid assembly.
Liang Y; Pingali SV; Jogalekar AS; Snyder JP; Thiyagarajan P; Lynn DG
Biochemistry; 2008 Sep; 47(38):10018-26. PubMed ID: 18759497
[TBL] [Abstract][Full Text] [Related]
32. Conformation and topology of amyloid beta-protein adsorbed on a tethered artificial membrane probed by surface plasmon field-enhanced fluorescence spectroscopy.
Song H; Ritz S; Knoll W; Sinner EK
J Struct Biol; 2009 Oct; 168(1):117-24. PubMed ID: 19576283
[TBL] [Abstract][Full Text] [Related]
33. Formation of toxic fibrils of Alzheimer's amyloid beta-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component.
Okada T; Wakabayashi M; Ikeda K; Matsuzaki K
J Mol Biol; 2007 Aug; 371(2):481-9. PubMed ID: 17582434
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of the formation of amyloid beta-protein fibrils using biocompatible nanogels as artificial chaperones.
Ikeda K; Okada T; Sawada S; Akiyoshi K; Matsuzaki K
FEBS Lett; 2006 Dec; 580(28-29):6587-95. PubMed ID: 17125770
[TBL] [Abstract][Full Text] [Related]
35. Beta-amyloid fibril formation is promoted by step edges of highly oriented pyrolytic graphite.
Losic D; Martin LL; Aguilar MI; Small DH
Biopolymers; 2006; 84(5):519-26. PubMed ID: 16752395
[TBL] [Abstract][Full Text] [Related]
36. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
[TBL] [Abstract][Full Text] [Related]
37. Using model membranes for the study of amyloid beta:lipid interactions and neurotoxicity.
Vestergaard M; Hamada T; Takagi M
Biotechnol Bioeng; 2008 Mar; 99(4):753-63. PubMed ID: 17994591
[TBL] [Abstract][Full Text] [Related]
38. Alzheimer's disease amyloid beta peptide 25-35 inhibits lipid peroxidation as a result of its membrane interactions.
Walter MF; Mason PE; Mason RP
Biochem Biophys Res Commun; 1997 Apr; 233(3):760-4. PubMed ID: 9168929
[TBL] [Abstract][Full Text] [Related]
39. Influence of cadmium and selenate on the interactions between hormones and phospholipids.
Gzyl-Malcher B; Filek M; Brezesinski G
Langmuir; 2009 Nov; 25(22):13071-6. PubMed ID: 19831406
[TBL] [Abstract][Full Text] [Related]
40. Amyloidogenic propensities and conformational properties of ProIAPP and IAPP in the presence of lipid bilayer membranes.
Jha S; Sellin D; Seidel R; Winter R
J Mol Biol; 2009 Jun; 389(5):907-20. PubMed ID: 19427320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
